Labcorp will use Ultima Genomics’ UG 100, a machine designed to sequence the genome for $100, to assess molecular residual disease.
Labcorp will use Ultima Genomics’ UG 100, a machine designed to sequence the genome for $100, to assess molecular residual disease.